Zydus Cadila Starts Supply Of Covid-19 Vaccine To Govt

Zydus Cadila Starts Supply Of Covid-19 Vaccine To Govt

By, Admin 2 February 2022

It Has Also Entered Into An Agreement With Enzychem Lifesciences Of The Republic Of Korea For The Manufacturing License And Technology Transfer For The Plasmid Dna Vaccine, Zydus Cadila Noted. Zydus Cadila On Wednesday Said It Has Commenced Supplies Of Its Covid-19 Vaccine Zycov-D To The Central Government. The Company Has Initiated The Supply As Per The Order Placed By The Government, The Drug Firm Said In A Statement. The Group Is Also Planning To Make The Vaccine Available In The Private Market, It Added. Zycov-D Is A Three-Dose Vaccine Administered Intradermally. "The Vaccine Will Be Priced At Rs 265 Per Dose And The Applicator Being Offered At Rs 93 Per Dose, Excluding Gst," Zydus Cadila Said. The Ahmedabad-Based Drugmaker Has Also Entered Into A Definitive Agreement With Shilpa Medicare Ltd, A Contract Manufacturing Organisation, To Produce Mutually Agreeable Doses Of Zycov-D. It Has Also Entered Into An Agreement With Enzychem Lifesciences Of The Republic Of Korea For The Manufacturing License And Technology Transfer For The Plasmid Dna Vaccine, Zydus Cadila Noted. Zycov-D Is A Plasmid Dna Vaccine That Produces The Spike Protein Of The Sarscov-2 Virus And Elicits An Immune Response Mediated By The Cellular And Humoral Arms Of The Human Immune System, Which Play A Vital Role In Protection From Disease As Well As Viral Clearance.

Optimize Your trial insights with Clival Database.

Are you exhausted from the uncertainty of trial insights pricing? Clival Database ensures the clarity in the midst of the global scenario for clinical trials to you.

Clival Database is one of the best databases that offers an outstanding number of clinical trial data in terms of 50,000+ molecules and from primary regulatory markets as well as new entrants like Indian and Chinese markets.

With Clival, you get accurate positioning of historical sales data, patent database, company profiling, safety & efficacy, and prediction of launch of new innovative molecules helping you to align your research and driving down the cost.

To add value, we further break down our analytics for you so that improving your operational effectiveness; optimizing your clinical trials; and offering you accurate and high-quality data at lowest possible prices becomes possible.

Elevate your trial success rate with the cutting-edge insights from Clival database.

Check it out today and make more informed sourcing decisions! Learn More!